0001181431-13-018345.txt : 20130321 0001181431-13-018345.hdr.sgml : 20130321 20130321195711 ACCESSION NUMBER: 0001181431-13-018345 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130321 FILED AS OF DATE: 20130321 DATE AS OF CHANGE: 20130321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: XANTHOPOULOS KLEANTHIS G CENTRAL INDEX KEY: 0001283304 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22245 FILM NUMBER: 13708854 MAIL ADDRESS: STREET 1: 9050 CAMINO SANTA FE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: APRICUS BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001017491 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870449967 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11975 EL CAMINO REAL, STREET 2: SUITE 300 CITY: SAN DIEGO, STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 222-8041 MAIL ADDRESS: STREET 1: 11975 EL CAMINO REAL, STREET 2: SUITE 300 CITY: SAN DIEGO, STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: NEXMED INC DATE OF NAME CHANGE: 19970311 4 1 rrd374969.xml FORM 4 X0306 4 2013-03-21 0 0001017491 APRICUS BIOSCIENCES, INC. APRI 0001283304 XANTHOPOULOS KLEANTHIS G 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130 1 0 0 0 Common Stock 2013-03-21 2013-03-21 4 S 0 2864 2.50 D 81511 I By Kleanthis & Gaylen Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011 The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting Person, which are subject to certain vesting conditions. /s/ Randy Berholtz by power of attorney for Kleanthis G. Xanthopoulos, Ph.D. 2013-03-21